Qingdao Haier Biomedical Co.,Ltd Stock

Equities

688139

CNE100003P25

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
36.93 CNY +7.17% Intraday chart for Qingdao Haier Biomedical Co.,Ltd +13.18% -8.86%
Sales 2024 * 2.78B 384M Sales 2025 * 3.68B 508M Capitalization 11.66B 1.61B
Net income 2024 * 506M 69.83M Net income 2025 * 744M 103M EV / Sales 2024 * 4.19 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.17 x
P/E ratio 2024 *
23.2 x
P/E ratio 2025 *
15.8 x
Employees 2,636
Yield 2024 *
-
Yield 2025 *
-
Free-Float 49.35%
More Fundamentals * Assessed data
Dynamic Chart
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024. CI
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qingdao Haier Biomedical Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares. CI
Qingdao Haier Biomedical Co.,Ltd authorizes a Buyback Plan. CI
CICC Elects Chairman, Vice Chairman MT
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 80 Yuan From 100 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 100 Yuan From 120 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Chaoli'an Technology Co., Ltd. announced that it expects to receive CNY 43 million in funding from Qingdao Haier Biomedical Co.,Ltd CI
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 120 Yuan From 126 Yuan, Keeps at Buy MT
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022. CI
More news
1 day+7.17%
1 week+13.18%
Current month+30.91%
1 month+28.41%
3 months+9.91%
6 months+5.73%
Current year-8.86%
More quotes
1 week
32.50
Extreme 32.5
37.87
1 month
26.93
Extreme 26.93
37.87
Current year
25.50
Extreme 25.5
42.49
1 year
25.50
Extreme 25.5
73.49
3 years
25.50
Extreme 25.5
150.88
5 years
23.87
Extreme 23.87
150.88
10 years
23.87
Extreme 23.87
150.88
More quotes
Managers TitleAgeSince
Founder 54 05-10-27
Director of Finance/CFO 43 18-12-31
Chief Tech/Sci/R&D Officer 65 05-09-30
Members of the board TitleAgeSince
Director/Board Member 58 18-05-31
Chairman 54 18-05-31
Director/Board Member 52 18-02-28
More insiders
Date Price Change Volume
24-04-25 36.93 +7.17% 4 959 784
24-04-25 34.46 -0.69% 1,947,693
24-04-24 34.7 +3.77% 3,063,409
24-04-23 33.44 -0.62% 2,227,466
24-04-22 33.65 +2.59% 2,735,441

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
36.93 CNY
Average target price
57.5 CNY
Spread / Average Target
+55.70%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688139 Stock